[-] Show simple item record

dc.contributor.authorNeher, Jon O.eng
dc.contributor.authorMorton, Jacquelyn R.eng
dc.date.issued2004eng
dc.description.abstractErythromycin, clarithromycin, and azithromycin are equally effective in treating pneumonia caused by Mycoplasma pneumoniae or Chlamydophila (formerly Chlamydia) pneumoniae (strength of recommendation [SOR]: B, small head-to-head trials). Macrolide choice can be based on other considerations--cost, side effects, and effectiveness against other suspected pathogens (SOR: C, expert opinion).eng
dc.identifier.urihttp://hdl.handle.net/10355/3205eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2004 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 53, no. 03 (March 2004): 229-230.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectside effectseng
dc.subject.lcshMycoplasma Pneumoniaeeng
dc.subject.lcshChlamydophila Pneumoniaeeng
dc.subject.lcshMacrolide Antibioticseng
dc.subject.lcshErythromycineng
dc.titleWhat is the best macrolide for atypical pneumonia?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record